News
|
Careers
|
Contact Us
About Vanda
Development Pipeline
Discovery Research
Investor Relations
meet vanda
We are using pharmacogenetics to match promising molecules
to the right patients. So selecting the right medicine will be
easier, thanks to our more personal approach.
August 5, 2008
Vanda Pharmaceuticals Reports Second Quarter 2008 Results
July 31, 2008
Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
July 28, 2008
Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
June 26, 2008
Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Read More in the Newsroom
Iloperidone
VEC-162
VSF-173